PCSK9 and familial hypercholesterolemia: PathogenicLDLR variants, especially in the homozygous state, portend a greatly elevated and early-onset CVD risk, necessitating vigilant management and family screening APOB and PCSK9 variants contribute to hypercholesterolemia as well, but their association with clinical CVD appears weaker.